Oct
2026
Fiera Milano, Italy
Visit us
stand 3F9, API
Zone

Indena SpA

Exhibitor at CPHI Milan 2026
About Us

Indena is the Italian leading company in the identification, development and production of high-quality active principles derived from plants, for use in the pharmaceutical and health food industries. Backed up by over a century of botanical experience, the company invests a lot in R&D. CDMO activities are the priority in Indena’s strategic vision: today the Company has a multipurpose GMP plant with reactors from 250 lt to 10,000 lt (Stainless Steel, Hastelloy, Glass-lined); many Kilolabs for HPAPIs (OEL 1 ng/m3 or OEB6) also equipped with freeze-dryers for Payload-Linkers; two spray dryers, large and a mid-size, working with organic solvents; a 20-lt and a 250-liter hydrogenato...

  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Nutraceuticals
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 3F9, API

Products Featured at CPHI Milan 2026

  • Cannabidiol (from hemp)

    Product Cannabidiol (from hemp)

    Natural cannabinoid from hemp
  • Colchicine Ph. Eur.

    Product Colchicine Ph. Eur.

    Colchicine ph. eur. Botanical origin: gloriosa superba l. seed. Biological activity: antigout.
  • Colchicine Usp

    Product Colchicine Usp

    Colchicine usp. Botanical origin: gloriosa superba l. seed. Biological activity: antigout. 
  • Docetaxel

    Product Docetaxel

    Indena SpA offers a wide range of pharmaceutical products which includes docetaxel. Botanical origin: taxus baccata l. twig and leaf. Biological activity: anti-mitotic, anticancer. 
  • Paclitaxel

    Product Paclitaxel

    Paclitaxel belongs to the group of taxanes together with Docetaxel. It is marked by a powerful anticancer activity. This natural product, found as part of a National Cancer Institute program in 1962 aiming at identifying natural active compounds to potentially treat cancer, is a cell division inhibitor...

Indena S.p.A. Resources (1)

  • Industry Webinar Indena and TCG Greenchem Join Forces to Advance Next-Generation ADC Technologies

    This presentation introduces a new strategic collaboration between Indena, an Italian global leader in the development and production of high-quality active pharmaceutical ingredients (APIs) and highly potent APIs (HPAPIs), and TCG GreenChem, an innovative science-driven CDMO based in Princeton, USA. The goal of the partnership is to advance next generation ADC technologies and accelerate the development of innovative, sustainable payload–linkers for antibody-drug conjugates, by integrating Indena’s expertise in developing and producing high-potent payloads with TCG GreenChem’s advanced approaches in green chemistry, catalysis and biocatalysis, and “first-time-right” methodologies. By combining complementary capabilities, the two companies aim to provide ADC developers with faster and more efficient routes to clinical and commercial supply. The first milestone of this cooperation focuses on a novel payload–linker designed to showcase how this integrated approach can reduce development timelines and improve delivery to patients.